Skip to content
Home/Companies/Healthcare/Carvolix
Carvolix

Carvolix

Healthcare·France·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Carvolix?

Carvolix is currently owned by Truffle Capital through Truffle BioMedTech (2019 vintage), since 2026.

Hand-verified · updated 2026-06-11

Truffle Capital
Investor
Truffle Capital
Truffle BioMedTech · 2019 · Buyout

Key facts

HQFrance
SectorHealthcare
StatusActive
Websitewww.carvolix.eu

More from Truffle BioMedTech

Other portfolio companies in the same fund.

Hydrosat
Hydrosat
Active
ClimateTechUnited States· 2026
SpikImm
SpikImm
Active
HealthcareFrance· 2021
BariaTek
BariaTek
Active
HealthcareFrance· 2019
PK MED
PK MED
Active
HealthcareFrance· 2019
Affluent Medical
Active
HealthcareFrance· 2018
Vexim
Exited 2018
SoftwareFrance· 2016
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Carvolix

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Carvolix.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue